REQUEST PRICE

Fields with * are required
Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Immuno-Grade VIP Receptor 2 Antibody

Close filters
No results were found for the filter!
Citations
KO-Validated
Immunohistochemical identification of VIP Receptor 2 in small intestine.
VPAC2 (IHC-grade), VIP Receptor 2 Antibody
The VPAC2 antibody is directed against the distal end of the carboxyl-terminal tail of mouse, rat and human VIP receptor 2. It can be used to detect total VPAC2 receptors in Western blots independent of phosphorylation. The VPAC2...
$ 350.00

VPAC2 is a receptor for VIP, PACAP-38 and -27. VPAC2 activity is mediated by Gs proteins. VPAC2 receptors are abundant in lymphocytes present in spleen, tonsils, lymph nodes and Peyer’s patches, chief cells of gastric mucosa, exocrine and endocrine pancreas, kidney tubules and blood vessels. In the central nervous system, VPAC2 is abundant in the suprachiasmatic nuclei where it regulates the normal rhythmic activity of the circadian clock. In addition, VPAC2 was observed in thyroid, gastric and lung carcinomas, pancreatic adenocarcinomas, sarcomas and neuroendocrine tumors.

VPAC2 is a receptor for VIP, PACAP-38 and -27. VPAC2 activity is mediated by Gs proteins. VPAC2 receptors are abundant in lymphocytes present in spleen, tonsils, lymph nodes and Peyer’s patches,... read more »
Close window
Immuno-Grade VIP Receptor 2 Antibody

VPAC2 is a receptor for VIP, PACAP-38 and -27. VPAC2 activity is mediated by Gs proteins. VPAC2 receptors are abundant in lymphocytes present in spleen, tonsils, lymph nodes and Peyer’s patches, chief cells of gastric mucosa, exocrine and endocrine pancreas, kidney tubules and blood vessels. In the central nervous system, VPAC2 is abundant in the suprachiasmatic nuclei where it regulates the normal rhythmic activity of the circadian clock. In addition, VPAC2 was observed in thyroid, gastric and lung carcinomas, pancreatic adenocarcinomas, sarcomas and neuroendocrine tumors.

Recently viewed